SEARCH

SEARCH BY CITATION

References

  • 1
    Sudre P, Ten Dam G, Kochi A. Tuberculosis: a global overview of the situation today. Bull WHO 1992; 70 : 14959.
  • 2
    Kochi A. The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle 1991; 72 : 16.
  • 3
    Stead WW. Pathogenesis of a first episode of chronic pulmonary tuberculosis in man: recrudescence of residuals of the primary infection or exogenous reinfection? Am Rev Resp Dis 1967; 95 : 72945.
  • 4
    Raviglione MC, Snider DE, Kochi A. Global epidemiology of tuberculosis: morbidity and mortality of a global epidemic. JAMA 1995; 273 : 2206.
  • 5
    Antonucci G, Girardi E, Raviglione MC, Ippolito G. Risk factors for tuberculosis in HIV-infected persons: a prospective cohort study. JAMA 1995; 274 : 1438.
  • 6
    Narain JP, Raviglione MC, Kochi A. HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention. Tuber Lung Dis 1992; 73 : 31121.
  • 7
    McCune RM, Feldmann FM, McDermott W. Microbial persistence II. Characteristics of the sterile state of tubercle bacilli. J Exp Med 1966; 123 : 46986.
  • 8
    McCune RM, Feldmann FM, Lambert HP, McDermott W. Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues. J Exp Med 1966; 123 : 44568.
  • 9
    Brown DH, Miles BA, Zwilling BS. Growth of Mycobacterium tuberculosis in BCG-resistant and -susceptible mice: establishment of latency and reactivation. Infect Immunol 1995; 63 : 22437.
  • 10
    Orme IM. A mouse model of the recrudescence of latent tuberculosis in the elderly. Am Rev Respir Dis 1988; 137 : 7168.
  • 11
    Flynn JL, Scanga CA, Tanaka KE, Chan J. Effects of aminoguanidine on latent murine tuberculosis. J Immunol 1998; 160 : 1796803.
  • 12
    Mustafa T, Phyu S, Nilsen R, Johnson Bjune G. A mouse model for slowly progressive primary tuberculosis. Scand J Immunol 1999; 50 : 12736.
  • 13
    Phyu S, Mustafa T, Hofstad T, Nilsen R, Fosse R, Bjune G. A mouse model for latent tuberculosis. Scand J Infect Dis 1998; 30 : 5968.
  • 14
    Scanga CA, Mohan VP, Joseph H, Yu K, Chan J, Flynn JL. Reactivation of latent tuberculosis: variations on the Cornell murine model. Infect Immun 1999; 67 : 45318.
  • 15
    Marino MW, Dunn A, Grail D et al. Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci USA 1997; 94 : 80938.
  • 16
    Barry C, Cole S, Fourie B et al. Scientific blueprint for TB drug development. Tuberculosis 2001; 81 (Suppl. 1):152.
  • 17
    Grosset J. The sterilizing value of rifampicin and pyrazinamide in experimental short-course chemotherapy. Bull Int Union Tuberc 1978; 53[1 (Intanbul number)]:512.